|
ZMYM2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.804900E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.239100E-04 |
| Normal-vs-Stage2 |
1.699830E-01 |
| Normal-vs-Stage3 |
2.196500E-04 |
| Normal-vs-Stage4 |
1.381610E-04 |
| Stage1-vs-Stage2 |
6.135000E-01 |
| Stage1-vs-Stage3 |
2.214200E-01 |
| Stage1-vs-Stage4 |
2.106200E-01 |
| Stage2-vs-Stage3 |
1.786650E-01 |
| Stage2-vs-Stage4 |
1.653400E-01 |
| Stage3-vs-Stage4 |
6.060800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.362600E-04 |
| Normal-vs-AfricanAmerican |
6.135900E-03 |
| Normal-vs-Asian |
2.550200E-02 |
| Caucasian-vs-AfricanAmerican |
9.876400E-01 |
| Caucasian-vs-Asian |
7.550600E-01 |
| AfricanAmerican-vs-Asian |
7.533600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.620200E-04 |
| Normal-vs-Female |
4.716000E-02 |
| Male-vs-Female |
4.819200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.490280E-02 |
| Normal-vs-Extreme_Weight |
2.25669999999178E-05 |
| Normal-vs-Obese |
8.962400E-03 |
| Normal-vs-Extreme_Obese |
8.332100E-02 |
| Normal_Weight-vs-Extreme_Weight |
4.120800E-01 |
| Normal_Weight-vs-Obese |
6.810600E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.463600E-01 |
| Extreme_Weight-vs-Obese |
1.335410E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.888800E-01 |
| Obese-vs-Extreme_Obese |
6.138000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.150140E-04 |
| Normal-vs-Age(41-60Yrs) |
8.684400E-02 |
| Normal-vs-Age(61-80Yrs) |
6.00149999999688E-05 |
| Normal-vs-Age(81-100Yrs) |
4.23429999996117E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.360000E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.176400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.983600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.745820E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.540150E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.941800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.775500E-03 |
| Normal-VS-Type2 PRCC |
6.61940000035166E-07 |
| Normal-VS-KIRP CIMP |
6.44669999605441E-08 |
| Normal-VS-Unclassified PRCC |
4.041400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
4.263400E-03 |
| Type1 PRCC-VS-KIRP CIMP |
2.46649999979809E-07 |
| Type1 PRCC-VS-Unclassified PRCC |
5.379200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.615600E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
4.156300E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
3.411300E-04 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.0205000000596E-07 |
| Normal-vs-N1 |
1.036930E-03 |
| Normal-vs-N2 |
5.32462962610225E-13 |
| N0-vs-N1 |
2.082600E-01 |
| N0-vs-N2 |
5.987500E-04 |
| N1-vs-N2 |
6.173600E-04 |
|
|
